These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38078610)
1. Irritable bowel syndrome - less irritable, or better treatments? Travers P; Lacy BE; Cangemi DJ Curr Opin Gastroenterol; 2024 Jan; 40(1):27-33. PubMed ID: 38078610 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in pharmacological treatment of irritable bowel syndrome. Lazaraki G; Chatzimavroudis G; Katsinelos P World J Gastroenterol; 2014 Jul; 20(27):8867-85. PubMed ID: 25083060 [TBL] [Abstract][Full Text] [Related]
3. Microbiome and Its Role in Irritable Bowel Syndrome. Pimentel M; Lembo A Dig Dis Sci; 2020 Mar; 65(3):829-839. PubMed ID: 32026278 [TBL] [Abstract][Full Text] [Related]
4. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Harris LA; Baffy N Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910 [TBL] [Abstract][Full Text] [Related]
5. New treatment options for irritable bowel syndrome with predominant diarrhea. Weber HC Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):25-30. PubMed ID: 27875419 [TBL] [Abstract][Full Text] [Related]
6. Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel Syndrome. Stemboroski L; Schey R Gastroenterol Clin North Am; 2020 Sep; 49(3):607-621. PubMed ID: 32718573 [TBL] [Abstract][Full Text] [Related]
7. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Evans BW; Clark WK; Moore DJ; Whorwell PJ Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807 [TBL] [Abstract][Full Text] [Related]
8. Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome. Algera JP; Törnblom H; Simrén M Curr Opin Pharmacol; 2022 Oct; 66():102284. PubMed ID: 36067685 [TBL] [Abstract][Full Text] [Related]
9. Antibiotics and Probiotics for Irritable Bowel Syndrome. Goodoory VC; Ford AC Drugs; 2023 Jun; 83(8):687-699. PubMed ID: 37184752 [TBL] [Abstract][Full Text] [Related]
10. Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives. Liu R; Staller K Drug Des Devel Ther; 2020; 14():1391-1400. PubMed ID: 32308371 [TBL] [Abstract][Full Text] [Related]
11. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome. Rawla P; Sunkara T; Raj JP Life Sci; 2018 Nov; 212():176-181. PubMed ID: 30290187 [TBL] [Abstract][Full Text] [Related]
12. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059 [TBL] [Abstract][Full Text] [Related]
13. [The new guideline on irritable bowel syndrome: what is new?]. von Schassen H; Andresen V; Layer P Dtsch Med Wochenschr; 2021 Oct; 146(19):1243-1248. PubMed ID: 34553347 [TBL] [Abstract][Full Text] [Related]
14. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. Hulisz D J Manag Care Pharm; 2004; 10(4):299-309. PubMed ID: 15298528 [TBL] [Abstract][Full Text] [Related]
15. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota]. Fukudo S Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158 [TBL] [Abstract][Full Text] [Related]
17. A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers. Moshiree B; Heidelbaugh JJ; Sayuk GS Adv Ther; 2022 Sep; 39(9):4003-4020. PubMed ID: 35869354 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Treatment of Irritable Bowel Syndrome: A Review. Camilleri M JAMA; 2021 Mar; 325(9):865-877. PubMed ID: 33651094 [TBL] [Abstract][Full Text] [Related]
19. Evidence-based management of irritable bowel syndrome with diarrhea. Pimentel M Am J Manag Care; 2018 Jan; 24(3 Suppl):S35-S46. PubMed ID: 29372991 [TBL] [Abstract][Full Text] [Related]